Skip to main content
Back
MDBPF logo

Medibank Private Limited

Data quality: 100%
Oversold
MDBPF
OTC Financial Services Insurance - Specialty
$2.78
$0.00 (0.00%)
Mkt Cap: 7.66B
Day Range
$2.43 $2.78
52-Week Range
$1.99 $3.30
Volume
740
50D / 200D Avg
$2.95 / $3.09
Prev Close
$2.78

Price History

Financial Trends

Peer Comparison

vs Financial Services sector median (854 peers)

Metric Stock Sector Median
P/E 15.3 10.3
P/B 3.3 1.1
ROE % 21.6 11.7
Net Margin % 5.9 16.8
Rev Growth 5Y % 5.1 11.7
D/E 0.0 0.5

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $0.30
$0.28 – $0.31
 11 B 1
FY2028 $0.28
$0.27 – $0.29
 11 B 1
FY2027 $0.27
$0.25 – $0.28
 10 B 1

Key Takeaways

Revenue grew 5.07% annually over 5 years — modest growth
ROE of 21.58% indicates high profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 369.70M in free cash flow
Capital efficient — spends only 0.13% of revenue on capex
ROIC of 23.40% — excellent capital efficiency

Growth

Revenue Growth (5Y)
5.07%
Revenue (1Y)6.58%
Earnings (1Y)1.69%
FCF Growth (3Y)30.74%

Quality

Return on Equity
21.58%
ROIC23.40%
Net Margin5.86%
Op. Margin8.53%

Safety

Debt / Equity
0.00
Current RatioN/A
Interest Coverage66.25

Valuation

P/E Ratio
15.29
P/B Ratio3.28
EV/EBITDA9.62
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.58% Revenue Growth (3Y) 6.75%
Earnings Growth (1Y) 1.69% Earnings Growth (3Y) -1.01%
Revenue Growth (5Y) 5.07% Earnings Growth (5Y) 3.22%
Profitability
Revenue (TTM) 8.55B Net Income (TTM) 500.80M
ROE 21.58% ROA 10.65%
Gross Margin 22.13% Operating Margin 8.53%
Net Margin 5.86% Free Cash Flow (TTM) 369.70M
ROIC 23.40% FCF Growth (3Y) 30.74%
Safety
Debt / Equity 0.00 Current Ratio N/A
Interest Coverage 66.25 Dividend Yield 0.04%
Valuation
P/E Ratio 15.29 P/B Ratio 3.28
P/S Ratio 0.90 PEG Ratio 0.00
EV/EBITDA 9.62 Dividend Yield 0.04%
Market Cap 7.66B Enterprise Value 7.01B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 8.55B 8.02B 7.50B 7.09B 7.01B
Net Income 500.80M 492.50M 511.10M 393.90M 441.20M
EPS (Diluted) 0.18 0.18 0.19 0.14 0.16
Gross Profit 1.89B 1.73B 1.64B 1.41B 1.44B
Operating Income 728.80M 711.70M 727.10M 560.00M 632.30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4.70B 4.69B 4.39B 4.55B 3.92B
Total Liabilities 2.36B 2.38B 2.30B 2.61B 2.02B
Shareholders' Equity 2.34B 2.31B 2.08B 1.95B 1.91B
Total Debt 0.0 218.30M 55.30M 76.90M 93.40M
Cash & Equivalents 648.60M 691.00M 420.60M 596.70M 671.70M
Current Assets 0.0 4.75B 3.63B 3.68B 3.21B
Current Liabilities 0.0 0.0 1.31B 1.60B 1.04B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Value Value Investing (Warren Buffett)
#166 of 195
28

Recent Activity

Entered Value Investing (Warren Buffett)
Mar 24, 2026